O

ORIG3N

11 employees

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
DNA test
Personal Health
Molecular Biology
iPSC
Regenerative Medicine
Personalized Medicine
Stem Cell Research
Health Care
Pluripotent Stem Cells
Health and Wellness
DNA
Medical
Tissue Engineering

Date founded

2014

Funding rounds raised

Total raised

$20M

from 19 investors over 19 rounds

O

ORIG3N raised $14M on July 12, 2018

Investors: Spectrum Health Ventures, KTB Ventures, DEFTA Partners, DAOL Ventures, Mountain Group Partners, Haitong International Securities Group Limited, Vectr Ventures and Labcorp

O

ORIG3N raised $20M on June 27, 2017

Investors: Spectrum Health Ventures, DEFTA Partners, Syno Capital and Labcorp

O

ORIG3N raised $13M on December 12, 2015

Investors: Syno Capital, DEFTA Partners, Mountain Group Partners and Labcorp

O

ORIG3N raised $3.1M on February 5, 2015

Investors: KTB Ventures, DAOL Ventures and Mountain Group Partners

FAQ